WuXi AppTec Receives 2009 Schering-Plough Excellence Award

SHANGHAI, Oct. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.
(NYSE: WX), a leading pharmaceutical, biotechnology, and medical device
research and development outsourcing company, with operations in China and the
United States, today announced that it had received the 2009 Excellence Award
from Schering-Plough.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The award recognizes WuXi's contributions to Schering-Plough's success in
a range of research projects, from the creation of compound libraries to
medicinal chemistry. The partnership has grown in size and scope from a
handful of employees four years ago to a large, multidisciplinary team today.
WuXi has consistently exceeded Schering-Plough's expectations and earned high
customer satisfaction ratings. By developing a comprehensive internal
training system, implementing efficient project management, and kindling a
collaborative team spirit, the WuXi team has overcome numerous hurdles.
"We are pleased and honored to receive this award from Schering-Plough in
recognition of the efforts of our talented and dedicated team of scientists,"
commented Dr. Ge Li, Chairman and CEO of WuXi AppTec. "Commitment to
excellent customer service drives everything we do."
For more information, please contact:

Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com

Stephanie Liu (for the media)
Tel: +86-21-5046-4362
Email: pr@wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.

Ronald Aldridge, Director of Investor Relations, +1-201-585-2048, or
Ron_Aldridge@wuxiapptec.com, or Stephanie Liu (for the media),
+86-21-5046-4362, or pr@wuxiapptec.com, both of WuXi PharmaTech (Cayman) Inc.